The role of miR-153 and related upstream/downstream pathways in cancers: from a potential biomarker to treatment of tumor resistance and a therapeutic target

被引：0

作者：

Vahab Alamdari-Palangi

Khojaste Rahimi Jaberi

Abbas Rahimi Jaberi

Seyed Mohammad Gheibihayat

Majid Akbarzadeh

Amir Tajbakhsh

Amir Savardashtaki

机构：

[1] Shiraz University of Medical Sciences,Department of Molecular Medicine, School of Advanced Medical Sciences and Technologies

[2] Shiraz University of Medical Sciences,Department of Neuroscience, School of Advanced Medical Sciences and Technologies

[3] Shiraz University of Medical Sciences,Clinical Neurology Research Center

[4] Shahid Sadoughi University of Medical Sciences,Department of Medical Biotechnology, School of Medicine

[5] Shiraz University of Medical Sciences,Department of Internal Medicine

[6] Shiraz University of Medical Sciences,Pharmaceutical Sciences Research Center

[7] Shiraz University of Medical Sciences,Department of Medical Biotechnology, School of Advanced Medical Sciences and Technologies

[8] Shiraz University of Medical Sciences,Infertility Research Center

来源：

Medical Oncology | / 39卷

关键词：

MiR-153; Noninvasive; Biomarker; Therapeutics; Radiotherapy; Drug resistance; Long noncoding RNA; Circular RNA;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 18 条

[1] The role of miR-153 and related upstream/downstream pathways in cancers: from a potential biomarker to treatment of tumor resistance and a therapeutic target
Alamdari-Palangi, Vahab
Jaberi, Khojaste Rahimi
Jaberi, Abbas Rahimi
Gheibihayat, Seyed Mohammad
Akbarzadeh, Majid
Tajbakhsh, Amir
Savardashtaki, Amir
[J]. MEDICAL ONCOLOGY, 2022, 39 (05)
[2] The Regulation, Functions, and Signaling of miR-153 in Neurological Disorders, and Its Potential as a Biomarker and Therapeutic Target
Jaberi, Khojaste Rahimi
Alamdari-Palangi, Vahab
Jaberi, Abbas Rahimi
Esmaeli, Zahra
Shakeri, Abolfazl
Hayat, Seyed Mohammad Gheibi
Tajbakhsh, Amir
Savardashtaki, Amir
[J]. CURRENT MOLECULAR MEDICINE, 2023, 23 (09) : 863 - 875
[3] miR-153 as biomarker for cancer-functional role as tumor suppressor
Thakur, Saloni
Saini, Adesh K.
Das, Joydeep
Saini, Vipin
Balhara, Parin
Nanda, Jagpreet S.
Saini, Reena V.
[J]. BIOCELL, 2022, 46 (01) : 13 - 26
[4] MiR-92a Family: A Novel Diagnostic Biomarker and Potential Therapeutic Target in Human Cancers
Jiang, Min
Li, Xuelian
Quan, Xiaowei
Li, Xiaoying
Zhou, Baosen
[J]. FRONTIERS IN MOLECULAR BIOSCIENCES, 2019, 6
[5] MiR-21 in the Cancers of the Digestive System and Its Potential Role as a Diagnostic, Predictive, and Therapeutic Biomarker
Nguyen, Ha Thi
Kacimi, Salah Eddine Oussama
Nguyen, Truc Ly
Suman, Kamrul Hassan
Lemus-Martin, Roselyn
Saleem, Humaira
Do, Duy Ngoc
[J]. BIOLOGY-BASEL, 2021, 10 (05):
[6] The role of clusterin in prostate cancer: treatment resistance and potential as a therapeutic target
Muhammad, Lateef A.
Saad, Fred
[J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (09) : 1049 - 1061
[7] Long Non-coding RNA and microRNAs as Novel Potential Biomarker and Therapeutic Target in the Treatment of Gastrointestinal Cancers
Bahrami, Afsane
Khazaei, Majid
Avan, Amir
[J]. CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (39) : 4599 - 4600
[8] Potential dual role of KGF/KGFR as a target option in novel therapeutic strategies for the treatment of cancers and mucosal damages
Ceccarelli, Simona
Romano, Ferdinando
Angeloni, Antonio
Marchese, Cinzia
[J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2012, 16 (04) : 377 - 393
[9] To investigate the tumor promotion role of PLOD3 in colorectal cancer and its potential as a prognostic biomarker and therapeutic target
Wanhui Dong
Su Li
Wei Tang
Qingming Sun
Pei Zhu
Mingxing Wang
Bin Xu
[J]. Scientific Reports, 15 (1)
[10] The role of clusterin in prostate cancer: treatment resistance and potential as a therapeutic target (vol 15, pg 1049, 2015)
Lateef, Muhammad Abdul
Saad, Fred
[J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (01) : 131 - 131

← 1 2 →